デフォルト表紙
市場調査レポート
商品コード
925384

幹細胞製造の世界市場:成長、動向、予測(2020年~2025年)

Stem Cell Manufacturing Market - Growth, Trends, and Forecast (2020 - 2025)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 120 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
幹細胞製造の世界市場:成長、動向、予測(2020年~2025年)
出版日: 2020年02月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 120 Pages
納期: 2~3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の幹細胞製造市場は、2020年から2025年の期間にわたって約3.3%のCAGRで成長すると予測されています。市場の成長に起因する主な要因には、幹細胞の製造および保存における技術の進歩と、幹細胞製品の治療効果に関する一般の認識の高まりが含まれます。さらに、官民投資の拡大と幹細胞ベースの研究への資金調達の増加が市場の成長を後押ししています。ただし、代替治療の人気の高まりは、市場の成長の主な抑制要因です。

当レポートは世界の幹細胞製造市場について調査しており、市場機会や動向、成長および抑制要因、セグメント別や地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概要
  • 市場成長要因
    • 幹細胞の製造と保存における技術進歩
    • 幹細胞製品の治療効果に関する一般の認識の高まり
    • 幹細胞ベースの研究における官民投資と資金調達の拡大
  • 市場抑制要因
    • 幹細胞製造とバンキングの高い運用コスト
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 競争の激化

第5章 市場区分

  • 製品別
    • 文化メディア
    • 消耗品
    • 装置
    • 幹細胞株
  • 用途別
    • 幹細胞療法
    • 創薬と開発
    • 幹細胞バンキング
    • その他
  • エンドユーザー別
    • 製薬およびバイオテクノロジー企業
    • 細胞バンクと組織バンク
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ地域
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Anterogen
    • Becton, Dickinson and Company
    • Cellular ダイナミックs (Fujifilm Holdings Corporation)
    • Lonza Group
    • Stemcell Technologies
    • Medipost
    • Merck Group
    • Osiris Therapeutics
    • Pluristem Therapeutics
    • Bio-Rad Laboratories

第7章 市場機会および将来動向

目次
Product Code: 67972

The Stem Cell Manufacturing market is projected to grow with a CAGR of nearly 3.3% over the forecast period. The major factors attributing to the growth of the market include the technological advancements in stem cell manufacturing and preservation and growing public awareness about the therapeutic potency of stem cell products.

According to California Institute for Regenerative Medicine, for the millions of people around the world who suffer from incurable diseases and injury, Stem Cell Awareness Day, October 11th is a day to celebrate the scientific advances made to-date. Research and academic institutions and educators are encouraged to participate by hosting public talks and other activities and events in their community. Furthermore, the growing growing public-private investments and funding in stem cell-based research is boosting the market growth. However, the gaining popularity of alternative procedures is the major drawback of market growth.

Key Market Trends

Stem Cell Banking Segment is the Fastest Growing Segment in the Stem Cell Manufacturing Market.

Stem cell bank is a provision that stores stem cells developed from amniotic fluid for future use. Stem cell samples in private banks are stored specifically for use by the individual person from whom such cells have been collected and the banking costs are paid the person. The sample can later be recovered only by that individual and for the use by such individual or, in many cases, by her or his first-degree blood relatives.

The major factor driving the growth of the segment is the increasing public demand for cord blood stem cell banking and rising awareness regarding the prospective advantages of stem cell preservation. Furthermore, stem cells have been proven to treat approximately 80 diseases and disorders including hematopoietic disorders, immunodeficiency diseases, metabolic disorders, etc. With the continued increase in per capita disposable revenue across developing countries and an expected decrease in product costs associated with stem cell therapies, increasing public awareness and the adoption of stem cell therapies, are the reasons driving the segment growth.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to the factors such as the presence of key players, high concentration of stem cell research in the region, mounting public-private funding and grants to support the clinical evaluation of stem cells for various applications, robust research infrastructure, and raising public awareness on the therapeutic potency of stem cells. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth.

Competitive Landscape

The Stem Cell Manufacturing market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Anterogen, Becton, Dickinson and Company, Cellular Dynamics (Fujifilm Holdings Corporation), Lonza Group, Stemcell Technologies, Medipost, Merck Group, Osiris Therapeutics, Pluristem Therapeutics, Bio-Rad Laboratories.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Technological Advancements in Stem Cell Manufacturing and Preservation
    • 4.2.2 Growing Public Awareness About the Therapeutic Potency of Stem Cell Products
    • 4.2.3 Growing Public-Private Investments and Funding in Stem Cell-Based Research
  • 4.3 Market Restraints
    • 4.3.1 High Operational Costs Associated With Stem Cell Manufacturing and Banking
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Culture Media
    • 5.1.2 Consumables
    • 5.1.3 Instruments
    • 5.1.4 Stem Cell Lines
  • 5.2 By Application
    • 5.2.1 Stem Cell Therapy
    • 5.2.2 Drug Discovery and Development
    • 5.2.3 Stem Cell Banking
    • 5.2.4 Others
  • 5.3 By End-User
    • 5.3.1 Pharmaceutical and Biotechnology Companies
    • 5.3.2 Cell Banks and Tissue Banks
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Anterogen
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 Cellular Dynamics (Fujifilm Holdings Corporation)
    • 6.1.4 Lonza Group
    • 6.1.5 Stemcell Technologies
    • 6.1.6 Medipost
    • 6.1.7 Merck Group
    • 6.1.8 Osiris Therapeutics
    • 6.1.9 Pluristem Therapeutics
    • 6.1.10 Bio-Rad Laboratories

7 MARKET OPPORTUNITIES AND FUTURE TRENDS